Arsenic sulfide induces miR-4665-3p to inhibit gastric cancer cell invasion and migration

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. doi:10.1002/ijc.2551621351269
   PubMed Web of Science ®Google Scholar
• Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006;24(18):2903–2909. doi:10.1200/JCO.2005.05.024516782930
   PubMed Web of Science ®Google Scholar
• Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology. 2005;128(6):1567–1578.15887152
   PubMed Web of Science ®Google Scholar
• Zambon C-F, Basso D, Navaglia F, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2004;126(1):382–384.14753224
   PubMed Web of Science ®Google Scholar
• Yamaguchi N, Kakizoe T. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncol. 2001;2(2):88–94. doi:10.1016/S1470-2045(00)00225-411905800
   PubMed Web of Science ®Google Scholar
• Eun JW, Kim HS, Shen Q, et al. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis. J Pathol. 2018;244(1):107–119. doi:10.1002/path.499428991363
   PubMed Web of Science ®Google Scholar
• Lei C, Du F, Sun L, et al. miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death Dis. 2017;8(10):e3101. doi:10.1038/cddis.2017.51829022908
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–355. doi:10.1038/nature0287115372042
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.14744438
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806–811. doi:10.1038/358889486653
   PubMed Web of Science ®Google Scholar
• Yu Z, Jian Z, Shen SH, Purisima E, Wang E. Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos. Nucleic Acids Res. 2007;35(1):152–164. doi:10.1093/nar/gkl103217158157
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20. doi:10.1016/j.cell.2004.12.03515652477
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–866. doi:10.1038/nrc199717060945
   PubMed Web of Science ®Google Scholar
• Garofalo M, Croce CM. microRNAs: master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol. 2011;51:25–43. doi:10.1146/annurev-pharmtox-010510-10051720809797
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang S, Guo K, et al. miR-125a restrains cell migration and invasion by targeting STAT3 in gastric cancer cells. Onco Targets Ther. 2019;12:205–215. doi:10.2147/OTT.S16845430636883
   PubMed Web of Science ®Google Scholar
• Shi J, Gong L, Chen L, et al. MiR-618 suppresses metastasis in gastric cancer by downregulating the expression of TGF-beta2. Anat Rec (Hoboken). 2019. doi:10.1002/ar.v302.6
   Google Scholar
• Jiang M, Shi L, Yang C, et al. miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer. Cell Death Dis. 2019;10(1):32. doi:10.1038/s41419-019-1300-330631050
   PubMed Web of Science ®Google Scholar
• Zhang L, Kim S, Ding W, et al. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo. Drug Des Devel Ther. 2015;9:5579–5590. doi:10.2147/DDDT.S89805
   PubMed Web of Science ®Google Scholar
• Zhang L, Tian W, Kim S, Ding W, Tong Y, Chen S. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo. Drug Des Devel Ther. 2015;9:79–92. doi:10.2147/DDDT.S74379
   PubMed Web of Science ®Google Scholar
• Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9(4):265–273. doi:10.1038/nrc262019262571
   PubMed Web of Science ®Google Scholar
• Ding K, Tan S, Huang X, et al. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. J Biol Chem. 2018;293(11):3949–3964. doi:10.1074/jbc.RA117.00110329367342
   PubMed Web of Science ®Google Scholar
• Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol. 2011;223(2):102–115. doi:10.1002/path.280621125669
   PubMed Web of Science ®Google Scholar
• Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18(2):128–134. doi:10.1038/nrc.2017.11829326430
   PubMed Web of Science ®Google Scholar
• Kim NH, Kim HS, Li X-Y, et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol. 2011;195(3):417–433. doi:10.1083/jcb.20110309722024162
   PubMed Web of Science ®Google Scholar
• Martello G, Rosato A, Ferrari F, et al. A MicroRNA targeting dicer for metastasis control. Cell. 2010;141(7):1195–1207. doi:10.1016/j.cell.2010.05.01720603000
   PubMed Web of Science ®Google Scholar
• Zhou J, Tao D, Xu Q, Gao Z, Tang D. Expression of E-cadherin and vimentin in oral squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8(3):3150–3154.26045832
   PubMed Web of Science ®Google Scholar
• Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin Cancer Res. 2005;11(22):8063–8069. doi:10.1158/1078-0432.CCR-05-064616299237
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee SJ, Jin SM, et al. Relationships between lymph node metastasis and expression of CD31, D2-40, and vascular endothelial growth factors A and C in papillary thyroid cancer. Clin Exp Otorhinolaryngol. 2012;5(3):150–155. doi:10.3342/ceo.2012.5.3.15022977712
   PubMed Web of Science ®Google Scholar
• Hakimi MA, Dong Y, Lane WS, Speicher DW, Shiekhattar R. A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J Biol Chem. 2003;278(9):7234–7239. doi:10.1074/jbc.M20899220012493763
   PubMed Web of Science ®Google Scholar
• Chai P, Tian J, Zhao D, et al. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion. Biochem Biophys Res Commun. 2016;471(1):123–128. doi:10.1016/j.bbrc.2016.01.16826828271
   PubMed Web of Science ®Google Scholar